Share Prices & Company Research

Market News

01 Apr 2021 | 10:08

Thruvision experiences 'weak' H2 in customs and aviation units

(Sharecast News) - X-ray manufacturer Thruvision experienced a "weak" second half in both its customs and aviation sub-sectors due to the Covid-19 pandemic. However, while Thruvision said on Thursday that the pandemic had adversely impacted revenues, its profit protection sub-sector "performed strongly" and continued to strengthen throughout 2020.

As a result, the AIM-listed group expects full-year revenues to be around £6.7m, down from £8.0m a year earlier, with a "consequential impact" on profitability.

Thruvision added that it had continued to manage costs proactively, partly due to reduced travel, and consequently cash was £7.3m on 31 March, up from £5.0m at the time of its interim report card in late September.

"As lock-down restrictions ease, particularly in the UK and US, and with a number of major new name customers in profit protection, we are well positioned to benefit from the rapid growth in this market where the effectiveness of our 'hands off' security screening is rapidly gaining traction with online retailers and their logistics partners," said Thruvision.

The group added that it also expects to benefit from the aviation sector's recovery and to see a resumption of orders in customs over the next 12 months.

As of 1005 BST, Thruvision shares were down 6.38% at 22.0p.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.